The dual mechanisms by which Trim21 exacerbates injury in AKI indicate that targeting its specific domains might serve as a potential intervention strategy for AKI, thereby uncovering novel therapeutic approaches for this clinically significant disorder. The gene discussed is TRIM21; the disease is acute kidney injury.